|
|
DSpace at RU >
Browsing by Author Niederwieser, D.
Showing results 1 to 32 of 32
| Full Text | Issue Date | Title | Author(s) | | 2011 | Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation | Gratwohl, A.; Brand, R.; Niederwieser, D.; Baldomero, H.; Chabannon, C., et al |
| 2011 | Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up | Bjorkstrand, B.; Iacobelli, S.; Hegenbart, U.; Gruber, A.; Greinix, H., et al |
| 2011 | The European LeukemiaNet: achievements and perspectives | Hehlmann, R.; Grimwade, D.; Simonsson, B.; Apperley, J.; Baccarani, M., et al |
| 2011 | Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation | Michallet, M.; Dreger, P.; Sutton, L.; Brand, R.; Richards, S., et al |
| 2011 | Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis | Kroger, N.; Zabelina, T.; Biezen, A. van; Brand, R.; Niederwieser, D., et al |
| 2010 | Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation. | Kroger, N.; Shimoni, A.; Schilling, G.; Schwerdtfeger, R.; Bornhauser, M., et al |
| 2010 | Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT. | Chalandon, Y.; Passweg, J.R.; Schmid, C.; Olavarria, E.; Dazzi, F., et al |
| 2010 | Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. | Ljungman, P.; Bregni, M.; Brune, M.; Cornelissen, J.; Witte, T.J.M. de, et al |
| 2010 | Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT. | Koenecke, C.; Hertenstein, B.; Schetelig, J.; Biezen, A. van; Dammann, E., et al |
| 2010 | The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry. | Michallet, M.; Sobh, M.; Milligan, D.; Morisset, S.; Niederwieser, D., et al |
| 2010 | Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia. | Dickinson, A.M.; Pearce, K.F.; Norden, J.; O'Brien, S.G.; Holler, E., et al |
| 2010 | Efficacy and outcome of autologous transplantation in rare myelomas. | Morris, C.; Drake, M.; Apperley, J.; Iacobelli, S.; Biezen, A. van, et al |
| 2010 | Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia. | Lim, Z.; Brand, R.; Martino, R.; Biezen, A. van; Finke, J., et al |
| 2009 | The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. | McCann, S.; Schwenkglenks, M.; Bacon, P.; Einsele, H.; D'Addio, A., et al |
| 2009 | Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival. | Witte, T.J.M. de; Brand, R.; Biezen, A. van; Mufti, G.J.; Ruutu, T., et al |
| 2009 | Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation. | Kroger, N.; Brand, R.; Biezen, A. van; Zander, A.; Dierlamm, J., et al |
| 2009 | Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. | Gratwohl, A.; Stern, M.; Brand, R.; Apperley, J.; Baldomero, H., et al |
| 2009 | Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. | Kroger, N.; Holler, E.; Kobbe, G.; Bornhauser, M.; Schwerdtfeger, R., et al |
| 2008 | Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group. | Blijlevens, N.; Schwenkglenks, M.; Bacon, P.; D'Addio, A.; Einsele, H., et al |
| 2008 | Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation. | Stern, M.; Brand, R.; Witte, T.J.M. de; Sureda, A.; Rocha, V., et al |
| 2008 | The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation. | Stelljes, M.; Biezen, A. van; Slavin, S.; Olavarria, E.; Clark, R.E., et al |
| 2007 | A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). | Al-Ali, H.K.; Brand, R.; Biezen, A. van; Finke, J.; Boogaerts, M., et al |
| 2007 | Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma. | Gahrton, G.; Iacobelli, S.; Bandini, G.; Bjorkstrand, B.; Corradini, P., et al |
| 2006 | The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes. | Witte, T.J.M. de; Brand, R.; Biezen, A. van; Delforge, M.; Biersack, H., et al |
| 2006 | Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. | Martino, R.; Iacobelli, S.; Brand, R.; Jansen, T.; Biezen, A. van, et al |
| 2006 | Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome. | Kroger, N.; Brand, R.; Biezen, A. van; Cahn, J.; Slavin, S., et al |
| 2005 | Stem cell transplantation from identical twins in patients with myelodysplastic syndromes. | Kroger, N.; Brand, R.; Biezen, A. van; Bron, D.; Blaise, D., et al |
| 2005 | The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. | Gahrton, G.; Iacobelli, S.; Apperley, J.; Bandini, G.; Bjorkstrand, B., et al |
| 1997 | Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation | Rhee, F. van; Szydlo, R.M.; Hermans, J.; Devergie, A.; Frassoni, F., et al |
| 1996 | Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia | Gratwohl, A.; Hermans, J.; Biezen, A. van; Arcese, W.; Debusscher, L., et al |
| 1995 | Acute Graft-versus-Host disease : grade and outcome in patients with chronic myelogenous leukemia | Gratwohl, A.; Hermans, J.; Apperley, J.; Arcese, W.; Bacigalupo, A., et al |
| 1995 | Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. | Kolb, H.J.; Schattenberg, A.V.M.B.; Goldman, J.; Hertenstein, B.; Jacobsen, N., et al |
Showing results 1 to 32 of 32
|